Cigarette smoking and othervascular risk factors in vasculogenic impotence

doi:10.1016/S0090-4295(91)80350-G

Urology

Volume 38, Issue 3, September 1991, Pages 227-231

https://doi.org/10.1016/S0090-4295(91)80350-G Get rights and content

Abstract

A total of 132 consecutive patients with erectile impotence underwent extensive evaluation, including vascular evaluation with intracavernous injection of papaverine and penile duplex ultrasonography, to determine the etiology of impotence. Three vascular risk factors, smoking, diabetes mellitus and hypertension, were investigated for their impact on vasculogenic impotence. The patients were divided into four groups: one with no risk factors, one with one vascular risk factor, one with two vascular risk factors, and one with all three risk factors. The results of penile vascular evaluation in these patient groups were compared. The incidence of penile vascular impairment was found to be higher in. patients with one vascular risk factor than in those with none. The proportion of abnormal penile vascular findings significantly increased as the number of risk factors increased. These data confirm the important role of vascular risk factors, smoking, diabetes mellitus, and hypertension, in the pathogenesis of organic impotence.

References (25)

ShabsighR. et al.
Evaluation of erectile impotence
Urology
(1988)
VelcekD.
Penile flow index utilizing a Doppler pulse wave analysis to identify penile vascular insufficiency
J Urol
(1980)
KediaK.R.
Penile plethysmography useful in diagnosis of vasculogenic impotence
Urology
(1983)
AbberJ.C.
Diagnostic tests for impotence: a comparison of papaverine injection with the penile brachial index and nocturnal penile tumescence
J Urol
(1986)
ShabsighR.
Evaluation of vasculogenic erectile impotence using penile duplex ultrasongraphy
J Urol
(1989)
GilbertD.G. et al.
The effects of cigarette smoking on human sexual potency
Addict Behav
(1986)
DePalmaR.G.
A screening sequence for vasculogenic impotence
J Vasc Surg
(1987)
ViragR. et al.
Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men
Lancet
(1985)
BuvatJ.
Comparative investigations in 26 impotent and 26 nonimpotent diabetic patients
J Urol
(1985)
KaracanI.
Impotence and blood pressure in the flaccid penisrelationship to nocturnal penile tumescence
Sleep
(1978)

KaracanI. et al.

Penile brachial index and organically impaired impotency cases

J Urol

(1989)

ViragR. et al.

Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure

Angiology

(1984)

Cited by (145)

The impact of erectile dysfunction on infertility and its treatment
2021, Psychological and Medical Perspectives on Fertility Care and Sexual Health
Sexual dysfunction can be a cause and effect of male infertility. A significant percentage of patients with male infertility will develop erectile dysfunction. Understanding the mechanisms of normal physiology and abnormal pathophysiology of erection function is important to treat underlying problem. Identification of the cause of the problem is important. Treatment options are herein described to optimize sexual function and optimize fertility in the male.
Smoking and men’s health
2019, Effects of Lifestyle on Men’s Health
Cigarette smoking remains one of the most significant preventable causes of disease and premature death in the western world and is a leading cause of cancer and death from cancer.
Over the past decades, mounting evidence has shown that cigarette smoking is associated with several malignant and nonmalignant urological diseases. In this regard, urologists can have a lasting impact on public health and patient quality of life by promoting a healthy lifestyle and ending dependence on cigarette smoking and nicotine.
In this chapter, we will point out several urological conditions that are associated with smoking behaviors to provide the reader with information and education regarding tobacco use and its effect on the development of fertility, testosterone levels, sexual function, and urological cancers.
The Predictive Value of Arteriogenic Erectile Dysfunction for Coronary Artery Disease in Men
2018, Journal of Sexual Medicine
Erectile dysfunction (ED) is assumed to be connected with vascular disease caused by endothelial dysfunction, and characterized by the incapability of the smooth muscle cells lining the arterioles to relax, therefore, inhibit vasodilatation.
To assess the predictive value of arteriogenic ED for coronary artery disease in men above the age of 40 years.
75 Patients reporting arteriogenic ED and 25 men with normal erectile function were enrolled in the study. Both patients and controls were subjected to the following investigations: lipid profile, fasting blood sugar, body mass index (BMI), waist circumference, penile duplex study, stress electrocardiography (ECG) test, International Index of Erectile Function (IIEF) Type 5 (Arabic version), and cardiovascular (CV) 10-year risk assessment using Framingham and Prospective Cardiovascular Münster (PROCAM) scoring systems.
We compare between the study groups regarding the interpretation of exercise testing.
We observed significant increase in the mean value of age, systolic blood pressure, BMI, weight, height, and waist circumference in the cases; significant prevalence of obesity and overweight in the cases (P < .001); significant increase in the mean value of total cholesterol, triglycerides (TG), and low-density lipoprotein; and decrease in mean value of high-density lipoprotein in the cases (P < .001). Additionally, there was high incidence of positive stress ECG in the cases (25.3%) vs that in controls (12%), and significant difference between patients with positive stress ECG test and those with negative stress ECG test regarding their lipid profile, age, BMI, and waist circumference with higher values in positive stress ECG for total cholesterol, TG, and low-density lipoprotein, and lower value for high-density lipoprotein (P < .001). According to PROCAM and Framingham scoring systems 10-year risk assessment, there was a high significant difference between the cases and control groups with a higher score in cases than the control group with 30.7% of cases having ≥ 30% risk of developing coronary heart disease, and significant positive correlations between CV risk and BMI, and negative correlations with IIEF-5 cases (P < .001).
Ischemic heart disease events were higher in men with documented arteriogenic ED than those without ED.
All items of metabolic syndrome were investigated and analyzed and we evaluated our groups using both PROCAM and Framingham scoring system. An exercise ECG is suggested before starting treatment of vasculogenic ED at least in patients with CV risk factors.
Azab SS, Hosni HED, El Far TA, et al. The Predictive Value of Arteriogenic Erectile Dysfunction for Coronary Artery Disease in Men. J Sex Med 2018;15:880–887.
Male Sexual Function and Smoking
2016, Sexual Medicine Reviews
Citation Excerpt :
Also, this study found significant correlations between the number of cigarettes smoked per day and the magnitude of these decreases in PBI for the left dorsal artery (r = −0.14, P = .01) and right cavernosal artery (r = −0.13, P < .03). When pharmacologically stimulating an erection before Doppler analysis, Shabsigh et al55 found a marginally significant difference in vascular impairment between smokers and non-smokers. Vascular morphology also has been analyzed by arteriography.
Erectile dysfunction (ED) is a common disorder that has many potential etiologies, including hormonal imbalances, psychogenic factors, neurologic disorders, vascular insufficiency, and other risk factors. Cigarette smoking has been well established as a risk factor for cardiovascular disease and stroke, but the relation between smoking and ED is less frequently considered.
To review the current literature that analyzes the association between cigarette smoking and ED.
The PubMed database was searched using the terms erectile dysfunction and smoking and erectile dysfunction and tobacco through December 2015.
Main outcome measures were significant changes in erectile function in relation to smoking status.
Eighty-three studies and articles were reviewed. Multiple human studies, animal studies, case series, cross-sectional, and cohort studies analyzed the relation between smoking or nicotine and ED.
There is substantial evidence showing that cigarette smoking is a risk factor for ED. Multiple human, animal, case series, cross-sectional, and cohort studies support this conclusion. A positive dose-response relation also is suggested such that increased quantity and duration of smoking correlate with a higher risk of ED. Smoking cessation can lead to recovery of erectile function, but only if limited lifetime smoking exposure exists. Smoking contributes to ED in different ways, especially by causing penile vasospasm and increased sympathetic nervous system tone.
Examining Penile Sensitivity in Neonatally Circumcised and Intact Men Using Quantitative Sensory Testing
2016, Journal of Urology
Little is known about the long-term implications of neonatal circumcision on the penile sensitivity of adult men, despite recent public policy endorsing the procedure in the United States. In the current study we assessed penile sensitivity in adult men by comparing peripheral nerve function of the penis across circumcision status.
A total of 62 men (age 18 to 37 years, mean 24.2, SD 5.1) completed study procedures (30 circumcised, 32 intact). Quantitative sensory testing protocols were used to assess touch and pain thresholds (modified von Frey filaments) and warmth detection and heat pain thresholds (a thermal analyzer) at a control site (forearm) and 3 to 4 penile sites (glans penis, midline shaft, proximal to midline shaft and foreskin, if present).
Penile sensitivity did not differ across circumcision status for any stimulus type or penile site. The foreskin of intact men was more sensitive to tactile stimulation than the other penile sites, but this finding did not extend to any other stimuli (where foreskin sensitivity was comparable to the other sites tested).
Findings suggest that minimal long-term implications for penile sensitivity exist as a result of the surgical excision of the foreskin during neonatal circumcision. Additionally, this study challenges past research suggesting that the foreskin is the most sensitive part of the adult penis. Future research should consider the direct link between penile sensitivity and the perception of pleasure/sensation. Results are relevant to policy makers, parents of male children and the general public.
Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases
2016, Journal of Sexual Medicine
Various factors play a role in the development of erectile dysfunction (ED).
To provide a descriptive comparison of erectile function response for tadalafil on-demand (PRN) and once-daily (OAD) dosing regimens in patients with common comorbid conditions, treatments, or risk factors that can be considered when treating ED.
In total, 17 PRN and 4 OAD placebo-controlled studies were included in the integrated database in these pooled analyses. Data were analyzed from patients treated with placebo, tadalafil 10 mg (low dose), and 20 mg (high dose) for the PRN studies and placebo, tadalafil 2.5 mg (low dose), and 5 mg (high dose) for the OAD studies.
The effects of tadalafil were measured using the International Index of Erectile Function administered from baseline to week 12. A descriptive comparison of the efficacy of tadalafil PRN vs OAD was examined in the clinical populations.
Baseline characteristics of 4,354 men were comparable between the PRN and OAD groups, with differences seen only in the variables of race, body mass index (BMI) of at least 30 kg/m², and alcohol use. Tadalafil was efficacious at improving erectile function for all clinical populations, except for the low-dose OAD group, which demonstrated a weaker effect vs placebo than the high-dose OAD group, and the low- and high-dose PRN groups vs placebo for patients with BMI of at least 30 kg/m² for patients without a cardiovascular disorder, smokers, patients with ED duration shorter than 1 year, and patients without previous phosphodiesterase type 5 inhibitor use. Tadalafil was efficacious for patients with or without diabetes mellitus, arterial hypertension, hyperlipidemia, and alcohol use at baseline.
Tadalafil OAD and PRN regimens showed efficacy in patients with ED. No clinical populations of patients with ED seemed to benefit overwhelmingly from one dose regimen over the other.

View all citing articles on Scopus

View full text

Scientific articleCigarette smoking and othervascular risk factors in vasculogenic impotence

Abstract

Urology

J Urol

Urology

J Urol

J Urol

Addict Behav

J Vasc Surg

Lancet

J Urol

Impotence and blood pressure in the flaccid penisrelationship to nocturnal penile tumescence

Sleep

Penile brachial index and organically impaired impotency cases

J Urol

Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure

Angiology

Scientific article
Cigarette smoking and othervascular risk factors in vasculogenic impotence